MEGAN PAYNE: Open Payments
NPI 1134622095 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,309 in 108 payments from 14 companies in 2025. Trend: 2023 $8,976 · 2024 $2,409 · 2025 $2,309
Food & beverage: $2,237Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 40 | $802 |
| Galderma Laboratories, L.P. | 11 | $330 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $214 |
| ABBVIE INC. | 10 | $213 |
| Regeneron Healthcare Solutions, Inc. | 8 | $178 |
| Botanix SB Inc | 9 | $139 |
| Incyte Corporation | 5 | $111 |
| GENZYME CORPORATION | 2 | $75 |
| UCB, Inc. | 2 | $70 |
| LEO Pharma Inc. | 3 | $62 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, ILUMYA, SOFDRA, RINVOQ, OPZELURA, SKYRIZI.
Industry payments across PA — which companies pay providers there.
